Search research articles
Contact Us
Filters
Showing results (151-160 of 180) with videos related to
Page
of 18
Sort By:
Exploration of Targeted Anti-Tumor Therapy
|
April 20, 2022
Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα, and cell-cycle signaling in a breast cancer model
Kate M Moore, Vera Cerqueira, Kenneth G MacLeod, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 7, 2000
A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues
J Pan, E J Kunkel, U Gosslar, et al.
Cancer Research
|
August 6, 2009
Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma
Wataru Sakai, Elizabeth M Swisher, Céline Jacquemont, et al.
British Journal of Cancer
|
August 1, 1992
Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells
G J Rabiasz, S P Langdon, J M Bartlett, et al.
British Journal of Cancer
|
August 1, 1990
Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines
S P Langdon, M M Hawkes, S S Lawrie, et al.
BMC Cancer
|
June 6, 2018
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment
Chrysi Xintaropoulou, Carol Ward, Alan Wise, et al.
International Journal of Cancer
|
September 30, 1993
Contrasting effects of 17 beta-estradiol on the growth of human ovarian carcinoma cells in vitro and in vivo
S P Langdon, A Ritchie, K Young, et al.
Cancer Research
|
November 15, 1987
Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine
M F Stevens, J A Hickman, S P Langdon, et al.
European Journal of Medicinal Chemistry
|
August 17, 2019
Carbonic anhydrase inhibitors based on sorafenib scaffold: Design, synthesis, crystallographic investigation and effects on primary breast cancer cells
Murat Bozdag, Marta Ferraroni, Carol Ward, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 1998
Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen
S P Langdon, H Gabra, J M Bartlett, et al.
Page
of 18
Search research articles
Search
Showing results (151-160 of 180) with videos related to
Sort By:
Page
of 18
Exploration of Targeted Anti-Tumor Therapy
|
April 20, 2022
Collateral-resistance to estrogen and HER-activated growth is associated with modified AKT, ERα, and cell-cycle signaling in a breast cancer model
Kate M Moore, Vera Cerqueira, Kenneth G MacLeod, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
September 7, 2000
A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues
J Pan, E J Kunkel, U Gosslar, et al.
Cancer Research
|
August 6, 2009
Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma
Wataru Sakai, Elizabeth M Swisher, Céline Jacquemont, et al.
British Journal of Cancer
|
August 1, 1992
Growth control by epidermal growth factor and transforming growth factor-alpha in human lung squamous carcinoma cells
G J Rabiasz, S P Langdon, J M Bartlett, et al.
British Journal of Cancer
|
August 1, 1990
Oestrogen receptor expression and the effects of oestrogen and tamoxifen on the growth of human ovarian carcinoma cell lines
S P Langdon, M M Hawkes, S S Lawrie, et al.
BMC Cancer
|
June 6, 2018
Expression of glycolytic enzymes in ovarian cancers and evaluation of the glycolytic pathway as a strategy for ovarian cancer treatment
Chrysi Xintaropoulou, Carol Ward, Alan Wise, et al.
International Journal of Cancer
|
September 30, 1993
Contrasting effects of 17 beta-estradiol on the growth of human ovarian carcinoma cells in vitro and in vivo
S P Langdon, A Ritchie, K Young, et al.
Cancer Research
|
November 15, 1987
Antitumor activity and pharmacokinetics in mice of 8-carbamoyl-3-methyl-imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one (CCRG 81045; M & B 39831), a novel drug with potential as an alternative to dacarbazine
M F Stevens, J A Hickman, S P Langdon, et al.
European Journal of Medicinal Chemistry
|
August 17, 2019
Carbonic anhydrase inhibitors based on sorafenib scaffold: Design, synthesis, crystallographic investigation and effects on primary breast cancer cells
Murat Bozdag, Marta Ferraroni, Carol Ward, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 25, 1998
Functionality of the progesterone receptor in ovarian cancer and its regulation by estrogen
S P Langdon, H Gabra, J M Bartlett, et al.
Page
of 18